1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Multiple System Atrophy (MSA): new trials by email Literature Review of Multiple System Atrophy (MSA) trials Research Report on Multiple System Atrophy (MSA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MSA-01 in Multiple System Atrophy MSA-01, Placebo - Multiple System Atrophy (MSA) | Phase 3 | Recruiting | Tokyo University | 140 | 2026-02-09 | 2026-03-04 |
| A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients DaTSCAN™ Ioflupane (123I) Injection - Parkinsonian Syndrome, Parkinson Disease(PD) | Phase 3 | Completed | GE Healthcare | 172 | 2020-06-28 | 2023-10-16 |
Multiple System Atrophy (2) · Essential Tremor (1) · Parkinson Disease (1) · Parkinsonian Disorders (1) · Supranuclear Palsy, Progressive (1)
Autonomic Nervous System Diseases (2) · Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Primary Dysautonomias (2) · Synucleinopathies (2) · Cranial Nerve Diseases (1) · Eye Diseases (1) · Neurologic Manifestations (1) · Ocular Motility Disorders (1) · Ophthalmoplegia (1) · Paralysis (1)
Injections (1) · Iodine-123 (1) · ioflupane (1)
GE Healthcare (1) · Tokyo University (1)
China (1) · Japan (1)